Compound information
- Natural Products
- ZC1897708
- Molecular Formula
- C18H21ClN4O
- Molecular Weight
- 344.140388972 g/mol
- Structure
-
- IUPAC Name
- N-(3-chloro-2-methyl-phenyl)-4-(3-pyridylmethyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C18H21ClN4O/c1-14-16(19)5-2-6-17(14)21-18(24)23-10-8-22(9-11-23)13-15-4-3-7-20-12-15/h2-7,12H,8-11,13H2,1H3,(H,21,24)
- InChI Key
- LRVKUBSUEUWVMG-UHFFFAOYSA-N
- SMILES
- Cc1c(Cl)cccc1NC(=O)N1CCN(Cc2cccnc2)CC1
- Source
- ZINC000013324867
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.622 |
LogS | -2.741 | LogD | 2.97 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.37 | Pgp substrate | 0.64 |
HIA | 0.963 | F20 % | 0.985 |
F30 % | 0.972 | Caco-2 | -4.866 |
MDCK | -4.756 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.735 | PPB | 92.839 |
VD | 1.345 | Fu | 0.624 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.075 | CYP1A2 substrate | 0.791 |
CYP2A6 substrate | 0.865 | CYP2B6 substrate | 0.767 |
CYP2C19 inhibitor | 0.785 | CYP2C19 substrate | 0.865 |
CYP2C8 substrate | 0.886 | CYP2C9 inhibitor | 0.803 |
CYP2C9 substrate | 0.993 | CYP2D6 inhibitor | 0.974 |
CYP2D6 substrate | 0.998 | CYP2E1 substrate | 0.92 |
CYP3A4 inhibitor | 0.579 | CYP3A4 substrate | 0.995 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.552 | CL | 11.273 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.279 | Hepatotoxicity | 0.664 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.847 |
FDAMDD | 0.524 | Skin Sensitization | 0.968 |
Carcinogenicity | 0.085 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.926 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.551 | IGC50 | 2.65 |
LC50FM | 2.753 | LC50DM | 0.135 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.409 | NR-AR-LBD | 0.204 |
NR-AhR | 0.776 | NR-Aromatase | 0.042 |
NR-ER | 0.349 | NR-ER-LBD | 0.341 |
NR-PPAR-gamma | 0.147 | SR-ARE | 0.86 |
SR-ATAD5 | 0.337 | SR-HSE | 0.188 |
SR-MMP | 0.015 | SR-p53 | 0.069 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.